Turku HIFU Research Centre currently has two clinical therapeutic ultrasound systems (Philips Sonalleve MR-HIFU and Profound TULSA-PRO) which are used to treat patients with uterine fibroids, bone metastases and prostate cancer. The ultrasound therapy platforms are integrated with Philips Ingenia 3T MRI scanner which is used for treatment planning and temperature monitoring.
Philips Ingenia 3.0T MR system
Ingenia 3.0T MR system is used for treatment planning by acquiring high-resolution MR images of the therapeutic area. The system is also used for the real-time monitoring of HIFU therapy with MR thermometry. The scanner is equipped with multiple coils for different physical locations in the body.
Philips Sonalleve MR-HIFU
Sonalleve MR-HIFU is an ultrasound therapy platform that integrates an advanced High Intensity Focused Ultrasound (HIFU) system into the patient table of Philips MRI systems (Philips Ingenia 3T). This allows you to perform non-invasive HIFU therapy supported by advanced planning and temperature monitoring using MR imaging. The system hence offers patients a non-invasive alternative to traditional surgical treatment or radiotherapy. At Turku HIFU Research Centre Sonalleve MR-HIFU is used for the treatment of uterine fibroids and palliative pain management of bone metastases.
TULSA-PRO combines real-time MRI with transurethral, robotically-driven therapeutic ultrasound and closed-loop thermal feedback control to provide precise ablation of the prostate while simultaneously actively protecting critical surrounding anatomy from potential side effects. The system provides patients with a new therapeutic alternative for the ablation of malignant tissue within the prostate. At Turku HIFU Research Centre the TULSA-PRO is used for the localised prostate cancer treatment.